Corporate venture capital in DACH
Updated 16 Nov 2026
Venture funds
4 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 4 |
| 2 | Hitachi Ventures Hitachi Ventures is the global venture capital arm of Hitachi Group, with recent investments in Thea Energy and Archetype AI. Munich, Germany |
Artificial intelligence, Biotech | Early stage venture | 19% | 2 |
| 3 | Leaps by Bayer Leaps by Bayer invests in biotechnology, agriculture and scientific breakthroughs, with recent investments in 9amHealth and CORXEL Pharmaceuticals. Leverkusen, Germany |
Health care, Biotech | Early stage venture | 40% | 2 |
| 4 | Novartis Venture Fund Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics. Basel, Switzerland |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 2 |
Table 1. Corporate venture capital in DACH: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| Bosch Ventures | Corporate venture arm | Stuttgart, Germany | •••@de.bosch.com | +49 71••• |
| UBS | Corporate venture arm | Zürich, Switzerland | •••@ubs.com | 41 44 ••• |
| Roche Venture Fund | Corporate venture arm | Basel, Switzerland | •••@roche.com | |
| SevenVentures | Corporate venture arm | Unterföhring, Germany | •••@sevenventures.de | |
| Neosfer | Corporate venture arm | Frankfurt, Germany | •••@neosfer.com | +49 69••• |
| EnBW New Ventures | Corporate venture arm | Karlsruhe, Germany | •••@env.vc | |
| Ringier Digital Ventures | Corporate venture arm | Zürich, Switzerland | •••@ringierdigital.ch |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 83 of the 124 corporate venture capital in DACH have a published email address, 60 a phone number and 120 a website.
- Novartis Venture Fund has the most recorded investments, 279, 75 of them as lead investor.
- 17 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Boehringer Ingelheim Venture Fund is an investor in 4 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Thea Energy's $20.0M Series B on 18 August 2026.
- Software is the most common sector across their 315 portfolio companies (64%).
- Early stage venture is the most common investment stage, recorded for 105 of them (85%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Corporate venture capital in DACH
30 of 124, most investments first| # | Investor | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Novartis Venture Fund | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 2 | Bosch Ventures | Stuttgart, Germany | Hardware, Artificial intelligence | Point2 Technology | 1 | 160 | 44 | 32 | •••@de.bosch.com | +49 71••• | In the CSV |
| 3 | UBS | Zürich, Switzerland | Fintech, Hardware | SWISSto12, MerQube, Nasdaq Private Market | 3 | 157 | 53 | 53 | •••@ubs.com | 41 44 ••• | In the CSV |
| 4 | Roche Venture Fund | Basel, Switzerland | Health care, Biotech | Cour Pharmaceuticals Development | 1 | 121 | 15 | 41 | •••@roche.com | In the CSV | |
| 5 | Leaps by Bayer | Leverkusen, Germany | Health care, Biotech | 9amHealth, CORXEL Pharmaceuticals | 2 | 113 | 45 | 13 | In the CSV | ||
| 6 | Boehringer Ingelheim Venture Fund | Ingelheim Am Rhein, Germany | Biotech, Health care | smartbax, xCures, Tacalyx | 4 | 99 | 47 | 12 | +49 61••• | ||
| 7 | BASF Venture Capital | Ludwigshafen, Germany | Biotech, Artificial intelligence | Computomics | 1 | 88 | 35 | 18 | 973 24••• | In the CSV | |
| 8 | ABB Ventures | Zürich, Switzerland | Artificial intelligence, Hardware | Sevensense Robotics, Enervalis, Numocity | 68 | 29 | 12 | In the CSV | |||
| 9 | Porsche Ventures | Stuttgart, Germany | Fintech, Hardware | KeySavvy, Retorio, INTAMSYS | 68 | 18 | 7 | In the CSV | |||
| 10 | Hitachi Ventures | Munich, Germany | Artificial intelligence, Biotech | Thea Energy, Archetype AI | 2 | 68 | 13 | 3 | In the CSV | ||
| 11 | SevenVentures | Unterföhring, Germany | Commerce, Fintech | presono, mybacs, BeautyLove | 64 | 14 | 17 | •••@sevenventures.de | In the CSV | ||
| 12 | Neosfer | Frankfurt, Germany | Fintech, Artificial intelligence | Vamo, Fairown, Bling.de | 56 | 14 | 9 | •••@neosfer.com | +49 69••• | In the CSV | |
| 13 | LBBW VC | Stuttgart, Germany | Biotech, Health care | Exciva | 1 | 47 | 14 | 7 | +49 71••• | In the CSV | |
| 14 | Siemens Financial Services | Munich, Germany | Energy, Hardware | Carbyon, FertigHy | 42 | 10 | 14 | +49 (8••• | In the CSV | ||
| 15 | EnBW New Ventures | Karlsruhe, Germany | Energy, Hardware | enspired, Sunhat, Cozero | 41 | 17 | 6 | •••@env.vc | In the CSV | ||
| 16 | Evonik Venture Capital | Hanau, Germany | Artificial intelligence, Hardware | Velox, HPNow, Castor Technologies LTD | 35 | 15 | 5 | +49 20••• | In the CSV | ||
| 17 | dRx Capital | Basel, Switzerland | Biotech, Health care | Dopavision | 31 | 4 | 8 | In the CSV | |||
| 18 | SIX FinTech Ventures | Zürich, Switzerland | Fintech, Artificial intelligence | Relio, Coinfirm, PXL Vision | 30 | 13 | 2 | +41 58••• | In the CSV | ||
| 19 | Ringier Digital Ventures | Zürich, Switzerland | Commerce, Health care | yamo, Archilyse AG, ABOUT YOU | 30 | 10 | 14 | •••@ringierdigital.ch | In the CSV | ||
| 20 | Axel Springer Digital Ventures | Berlin, Germany | Artificial intelligence, Commerce | Fineway, Familynet GmbH, Blendle | 28 | 6 | 10 | •••@axelspringer.de | In the CSV | ||
| 21 | Swiss Post Ventures | Bern, Switzerland | Commerce, Hardware | Classtime, CareerFairy, awork | 28 | 4 | 4 | ||||
| 22 | Elevator Ventures | Vienna, Austria | Fintech, Commerce | FINQware, SESAMm, Autenti | 27 | 14 | 4 | •••@elevator-ventures.com | (650) ••• | In the CSV | |
| 23 | TRUMPF Venture | Ditzingen, Germany | Artificial intelligence, Cybersecurity | Quside, Peers Solutions, ammune.ai | 27 | 12 | 4 | •••@trumpf.com | In the CSV | ||
| 24 | Bertelsmann Investments | Gütersloh, Germany | Health care, Artificial intelligence | QuantHealth | 1 | 24 | 3 | 2 | •••@bertelsmann.de | 490-52••• | In the CSV |
| 25 | Best Nights VC | Berlin, Germany | 22 | 0 | 1 | •••@bestnights.vc | In the CSV | ||||
| 26 | Porsche | Stuttgart, Germany | Hardware, Fintech | Bluedot, Sensigo, INTAMSYS | 21 | 5 | 3 | •••@gmail.com | In the CSV | ||
| 27 | Berliner Volksbank Ventures | Berlin, Germany | Fintech, Commerce | Qwist, VAI Trade, Inventorum | 20 | 5 | 5 | •••@volksbank-ventures.berlin | 030 30••• | In the CSV | |
| 28 | pd ventures | Augsburg, Germany | Software | Ryte, DS Digitale Seiten | 20 | 3 | 9 | •••@pdventures.de | +49 82••• | In the CSV | |
| 29 | Fluxunit - Osram Ventures | Munich, Germany | 19 | 3 | 3 | •••@fluxunit.de | +49896••• | In the CSV | |||
| 30 | Henkel Ventures | Düsseldorf, Germany | Hardware | Feelit | 18 | 9 | 1 | 0049-2••• |
Table 2. Corporate venture capital in DACH: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Boehringer Ingelheim Venture Fund | Ingelheim Am Rhein, Germany | 4 | 14 | smartbax, xCures, Tacalyx |
| 2 | UBS | Zürich, Switzerland | 3 | 26 | SWISSto12, MerQube, Nasdaq Private Market |
| 3 | Hitachi Ventures | Munich, Germany | 2 | 10 | Thea Energy, Archetype AI |
| 4 | Leaps by Bayer | Leverkusen, Germany | 2 | 13 | 9amHealth, CORXEL Pharmaceuticals |
| 5 | Novartis Venture Fund | Basel, Switzerland | 2 | 20 | Hepalink, FoRx Therapeutics |
| 6 | BASF Venture Capital | Ludwigshafen, Germany | 1 | 8 | Computomics |
| 7 | Symbia VC | Innsbruck, Austria | 1 | 2 | Strong by Form |
| 8 | Bosch Ventures | Stuttgart, Germany | 1 | 24 | Point2 Technology |
| 9 | Bertelsmann Investments | Gütersloh, Germany | 1 | 6 | QuantHealth |
| 10 | Archimedes New Ventures | Bielefeld, Germany | 1 | 2 | Additive Marking |
| 11 | Nabtesco Technology Ventures | Zürich, Switzerland | 1 | 1 | FOSSA Systems |
| 12 | Roche Venture Fund | Basel, Switzerland | 1 | 3 | Cour Pharmaceuticals Development |
| 13 | Verbund X Ventures | Vienna, Austria | 1 | 2 | SPiNE |
| 14 | Mücke Roth & Company | Munich, Germany | 1 | 4 | Qdrant |
| 15 | Enpulse | Stuttgart, Germany | 1 | 1 | Metiundo |
Table 3. Corporate venture capital in DACH: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Thea Energy | Thea Energy develops fusion energy technology to simplify the construction and operation of fusion power systems. | Energy | Kearny, United States | Series B | $20.0M | 2026-08-18 | $140.0M | Hitachi Ventures | 101 to 250 | 2022 |
| Computomics | Computomics applies artificial intelligence to genomics data to advance agricultural solutions. | Artificial intelligence | Tübingen, Germany | Series B | $7.3M | 2026-08-18 | $10.0M | BASF Venture Capital | 11 to 50 | 2012 |
| Point2 Technology | Point2 Technology develops dielectric waveguides for high-speed datacenter interconnects. | Energy | San Jose, United States | Series B | $80.0M | 2026-08-10 | $187.2M | Bosch Ventures | 51 to 100 | 2016 |
| QuantHealth | QuantHealth develops AI-powered clinical trial simulation software for pharmaceutical and biotechnology organizations. | Artificial intelligence | Tel Aviv, Israel | Series B | $45.0M | 2026-08-04 | $62.0M | Bertelsmann Investments | 101 to 250 | 2020 |
| SWISSto12 | SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. | Hardware | Renens, Switzerland | Series C | $70.0M | 2026-07-16 | $202.3M | UBS | 251 to 500 | 2011 |
| smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich, Germany | Seed | $5.5M | 2026-06-30 | $7.5M | Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
| FOSSA Systems | FOSSA Systems develops satellite infrastructure and connectivity solutions for space-based communications. | Hardware | Madrid, Spain | Series B | $6.8M | 2026-06-25 | $7.7M | Nabtesco Technology Ventures | 51 to 100 | 2020 |
| xCures | xCures aggregates, organizes, and structures electronic medical records across multiple diseases and data types. | Artificial intelligence | Oakland, United States | Series B | $46.0M | 2026-06-24 | $59.0M | Boehringer Ingelheim Venture Fund | 11 to 50 | 2018 |
| Cour Pharmaceuticals Development | Cour Pharmaceuticals Development develops nanoparticle technology to reset immune systems in multiple sclerosis patients. | Biotech | Skokie, United States | Series B | $50.0M | 2026-06-18 | $185.5M | Roche Venture Fund | 51 to 100 | 2015 |
| 9amHealth | 9amHealth offers a simplified approach to whole body health, including weight loss and diabetes management. | Health care | Encinitas, United States | Series B | $26.0M | 2026-05-12 | $55.2M | Leaps by Bayer | 251 to 500 | 2021 |
Table 4. Corporate venture capital in DACH: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 202 | 64% |
| Health care | 72 | 23% |
| Artificial intelligence | 71 | 23% |
| Hardware | 57 | 18% |
| Biotech | 53 | 17% |
| Fintech | 52 | 17% |
| Commerce | 26 | 8% |
| Energy | 18 | 6% |
| Education | 14 | 4% |
| Cybersecurity | 10 | 3% |
Table 5. Corporate venture capital in DACH: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 105 | 85% |
| Seed investors | 75 | 60% |
| Venture investors | 47 | 38% |
| Late stage investors | 40 | 32% |
| Private equity investors | 14 | 11% |
| Convertible note investors | 11 | 9% |
| Debt investors | 6 | 5% |
| Post IPO investors | 4 | 3% |
Table 6. Corporate venture capital in DACH by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| Germany | 87 | 70% |
| Switzerland | 30 | 24% |
| Austria | 6 | 5% |
| Liechtenstein | 1 | 1% |
Table 7. Corporate venture capital in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| Berlin | 11 | 9% |
| Zürich | 10 | 8% |
| Munich | 9 | 7% |
| Stuttgart | 7 | 6% |
| Frankfurt | 5 | 4% |
| Vienna | 4 | 3% |
| Düsseldorf | 4 | 3% |
| Cologne | 4 | 3% |
| Geneva | 4 | 3% |
| Hamburg | 4 | 3% |
| Basel | 3 | 2% |
| Gütersloh | 3 | 2% |
Table 8. Corporate venture capital in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 15 | 13% |
| 2010s | 58 | 51% |
| 2000s | 14 | 12% |
| 1990s | 8 | 7% |
| 1980s | 1 | 1% |
| 1970s | 2 | 2% |
Table 9. Corporate venture capital in DACH by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investor types include corporate venture arm and its headquarters is in DACH. On 16 November 2026 that is 124 investors.
- 83 rows carry an email address and 60 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 124 rows: 4 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many corporate venture capital in DACH are on the list?
- 124, in the file dated 16 November 2026. 17 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 83 of the 124 carry an email address in the download and 60 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 124 rows, 83 firm email addresses and 60 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 56 of the 83 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.